Stockreport

GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting® 2025 [Yahoo! Finance]

GENFIT S.A. - American Depositary Shares  (GNFT) 
PDF Safety data from Phase 1 on healthy volunteers and initial efficacy signals from ex-vivo functional assays expected by year-end 2025 Lille (France), Cambridge (Massac [Read more]